Home
/
Contineum Therapeutics, Inc.
/
Financials
/
Quarterly
Contineum Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Contineum Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 6, 2024
Q2
2024
Jun 30, 2024
$0
Aug 14, 2024
Q3
2024
Sep 30, 2023
$0
Nov 6, 2024
Q2
2024
Jun 30, 2023
$50.00M
Aug 14, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($12.79M)
Oct 30, 2025
Q3
2025
Jun 30, 2025
($16.04M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($16.04M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($15.99M)
May 14, 2025
Q3
2025
Mar 31, 2025
($15.99M)
Oct 30, 2025
Q2
2025
Mar 31, 2025
($15.99M)
Aug 5, 2025
Q3
2025
Sep 30, 2024
($10.27M)
Oct 30, 2025
Q3
2025
Jun 30, 2024
($9.01M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($9.01M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($8.42M)
May 14, 2025
Q2
2025
Mar 31, 2024
($8.42M)
Aug 5, 2025
Q3
2025
Mar 31, 2024
($8.42M)
Oct 30, 2025
Q3
2024
Sep 30, 2023
($6.25M)
Nov 6, 2024
Q3
2024
Jun 30, 2023
$41.56M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$41.56M
Aug 14, 2024
Q2
2024
Mar 31, 2023
($4.82M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.82M)
May 16, 2024
Q3
2024
Mar 31, 2023
($4.82M)
Nov 6, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.93M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($17.90M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($18.11M)
May 14, 2025
Q3
2025
Sep 30, 2024
($12.97M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($10.94M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($9.93M)
May 14, 2025
Q3
2024
Sep 30, 2023
($8.07M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
$38.94M
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.12M)
May 16, 2024